Literature DB >> 11129488

ROC curve estimation when covariates affect the verification process.

C Rodenberg1, X H Zhou.   

Abstract

A receiver operating characteristic (ROC) curve is commonly used to measure the accuracy of a medical test. It is a plot of the true positive fraction (sensitivity) against the false positive fraction (1-specificity) for increasingly stringent positivity criterion. Bias can occur in estimation of an ROC curve if only some of the tested patients are selected for disease verification and if analysis is restricted only to the verified cases. This bias is known as verification bias. In this paper, we address the problem of correcting for verification bias in estimation of an ROC curve when the verification process and efficacy of the diagnostic test depend on covariates. Our method applies the EM algorithm to ordinal regression models to derive ML estimates for ROC curves as a function of covariates, adjusted for covariates affecting the likelihood of being verified. Asymptotic variance estimates are obtained using the observed information matrix of the observed data. These estimates are derived under the missing-at-random assumption, which means that selection for disease verification depends only on the observed data, i.e., the test result and the observed covariates. We also address the issues of model selection and model checking. Finally, we illustrate the proposed method on data from a two-phase study of dementia disorders, where selection for verification depends on the screening test result and age.

Entities:  

Mesh:

Year:  2000        PMID: 11129488     DOI: 10.1111/j.0006-341x.2000.01256.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  9 in total

1.  Semiparametric estimation of the covariate-specific ROC curve in presence of ignorable verification bias.

Authors:  Danping Liu; Xiao-Hua Zhou
Journal:  Biometrics       Date:  2011-03-01       Impact factor: 2.571

2.  Estimating the agreement and diagnostic accuracy of two diagnostic tests when one test is conducted on only a subsample of specimens.

Authors:  Hormuzd A Katki; Yan Li; David W Edelstein; Philip E Castle
Journal:  Stat Med       Date:  2011-12-04       Impact factor: 2.373

3.  A model for adjusting for nonignorable verification bias in estimation of the ROC curve and its area with likelihood-based approach.

Authors:  Danping Liu; Xiao-Hua Zhou
Journal:  Biometrics       Date:  2010-12       Impact factor: 2.571

4.  Direct estimation of the area under the receiver operating characteristic curve in the presence of verification bias.

Authors:  Hua He; Jeffrey M Lyness; Michael P McDermott
Journal:  Stat Med       Date:  2009-02-01       Impact factor: 2.373

Review 5.  Estimation of diagnostic test accuracy without full verification: a review of latent class methods.

Authors:  John Collins; Minh Huynh
Journal:  Stat Med       Date:  2014-06-09       Impact factor: 2.373

6.  Estimation of the ROC curve under verification bias.

Authors:  Ronen Fluss; Benjamin Reiser; David Faraggi; Andrea Rotnitzky
Journal:  Biom J       Date:  2009-06       Impact factor: 2.207

7.  Estimation of the disease-specific diagnostic marker distribution under verification bias.

Authors:  John H Page; Andrea Rotnitzky
Journal:  Comput Stat Data Anal       Date:  2009-01-15       Impact factor: 1.681

8.  Diagnostic test evaluation methodology: A systematic review of methods employed to evaluate diagnostic tests in the absence of gold standard - An update.

Authors:  Chinyereugo M Umemneku Chikere; Kevin Wilson; Sara Graziadio; Luke Vale; A Joy Allen
Journal:  PLoS One       Date:  2019-10-11       Impact factor: 3.240

9.  Bias in trials comparing paired continuous tests can cause researchers to choose the wrong screening modality.

Authors:  Deborah H Glueck; Molly M Lamb; Colin I O'Donnell; Brandy M Ringham; John T Brinton; Keith E Muller; John M Lewin; Todd A Alonzo; Etta D Pisano
Journal:  BMC Med Res Methodol       Date:  2009-01-20       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.